In 2025, Life Sciences and Health Care (LS&HC) companies face rapidly evolving regulatory paradigms that create transactional risks and require daily monitoring. After more than 70 national elections in 2024, the dust hasn’t fully settled, not least in the U.S., where President Trump has taken office for the second time. Indeed, political shifts across the world – coupled with geopolitical uncertainty – set the tone for changes to come.
Please see full publication below for more information.
